Bioshares Analyst Coverage: Three Phase II Shots at Goal

In the 22 April 2013 edition of Bioshares, Invion is covered in the piece ‘Three phase II shots at goal”, and is noted as “Speculative Buy Class A”.

The full article is reproduced below with the kind permission of Bioshares.

Posted in Analyst Coverage